ASPIrin in Reducing Events in Dialysis ( ASPIRED )
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 9082 participants.
Also called NCT04381143
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 9,082 participants
- Registry
-
NCT04381143
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04381143. Randomized; quadruple masking; primary purpose treatment. Start 2020-07-30 (actual); primary completion 2026-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ASPIrin in Reducing Events in Dialysis ( ASPIRED )
- Condition
- CKD (Chronic Kidney Disease) Stage 5D
- Intervention (Drug)
- Aspirin 100 mg Oral Tablet
- Intervention (Drug)
- Matching Placebo
- Lead sponsor
- Guangdong Provincial People's Hospital
- Collaborator
- The George Institute
Record details
- Record id
cardio:ct-nct04381143- Content hash
3dd177f63ad937b63501de7e6f6ff25e56007973b4aa36d8f216cf0b39341911